Filing Details
- Accession Number:
- 0001209191-15-030196
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-03-30 17:13:52
- Reporting Period:
- 2015-03-19
- Filing Date:
- 2015-03-30
- Accepted Time:
- 2015-03-30 17:13:52
- Original Submission Date:
- 2015-03-23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189846 | L John Bishop | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Chairman Of The Board And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-19 | 25,000 | $19.85 | 75,274 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-03-19 | 25,000 | $60.00 | 50,274 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-03-19 | 25,000 | $0.00 | 25,000 | $19.85 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
100,000 | 2009-04-24 | 2015-04-24 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- Share total exercised and sold as corrected by broker after original report on Form 4 filed 3/23/15.
- 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.